Parallax Volatility Advisers’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,000
Closed -$2.01M 1801
2025
Q3
$2.01M Hold
15,000
﹤0.01% 921
2025
Q2
$1.87M Hold
15,000
﹤0.01% 909
2025
Q1
$1.91M Hold
15,000
0.01% 880
2024
Q4
$2.16M Buy
+15,000
New +$2.15M ﹤0.01% 1113
2024
Q2
Sell
-50,000
Closed -$9.2M 2239
2024
Q1
$9.2M Hold
50,000
0.02% 532
2023
Q4
$8.99M Buy
+50,000
New +$7.78M 0.02% 620
2022
Q3
Sell
-15,000
Closed -$2.44M 3314
2022
Q2
$2.44M Hold
15,000
﹤0.01% 1266
2022
Q1
$2.82M Buy
+15,000
New +$2.85M ﹤0.01% 1228

Other funds holding RGEN

Parallax Volatility Advisers's RGEN Position: Q4 2025 in Review

Parallax Volatility Advisers sold out of Repligen (RGEN) in Q4 2025, closing a stake of 11,314 shares — an estimated $1.51M sold.

Parallax Volatility Advisers first reported a position in RGEN in Q4 2017 and held it in 8 quarters. The position peaked at $1.75M in Q2 2022. 474 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

  • Parallax Volatility Advisers reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 11,314 Repligen shares in Q4 2025, an estimated $1.51M.
  • Parallax Volatility Advisers first reported a position in Repligen in Q4 2017 and held it in 8 quarters.
  • Parallax Volatility Advisers's Repligen position peaked at $1.75M in Q2 2022.
  • 474 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Parallax Volatility Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.